4
Changes in Ownership
KALA BIO, Inc. Filed Acc 0000921895-25-003208
Options or other derivatives
- Chief Executive Officer acquired 900,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lazar David E. · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-24 | Grant or award : show line 1 in the form Series AA Convertible Preferred Stock | +900,000 | 900,000 | D |
Loading xslF345X05/form412227001_11262025.xml…